Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01356771 · ClinicalTrials.gov registry record · NA
Melanoma Risk Assessment & Tailored Intervention
A NA study of Melanoma and Skin Cancer, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 323
- Enrollment target
- 1
- Study location
NCT01356771 is a NA study of Melanoma and Skin Cancer that has completed, run by University of Pennsylvania. The registered enrollment target is 323 participants, below the 705-participant average among 266 other Melanoma trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01356771, a NA study of Melanoma and Skin Cancer, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 323 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a study to provide evidence about the comparative effectiveness of mailed, tailored intervention materials on cancer prevention behavioral outcomes. The investigators will send out three (3) tailored mailings for participants who are assigned to the intervention group. Second, during the eligibility screening, the investigators will be assessing the relative yield and functioning of two risk assessment tools (BRAT and FEARS) on determining an individual's level of risk for skin cancer.
Conditions Studied
Interventions
- OTHER Surveys & Mailed Materials
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01356771
The ClinicalTrials.gov registry entry for NCT01356771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 705-participant average among 266 other Melanoma trials with a reported enrollment target (54% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Surveys & Mailed Materials is the first listed.
NCT01356771 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01356771 about?
NCT01356771 is a clinical study titled "Melanoma Risk Assessment & Tailored Intervention". The investigators are conducting a study to provide evidence about the comparative effectiveness of mailed, tailored intervention materials on cancer prevention behavioral outcomes. The investigators will send out three (3) tailored mailings for participants who are assigned to the intervention grou...
What is the current status of trial NCT01356771?
This trial is currently completed. It is a NA study. The enrollment target is 323 participants. The study started on 2011-05. Estimated completion is 2016-02.
What conditions does trial NCT01356771 study?
This clinical trial studies the following conditions: Melanoma, Skin Cancer.
What interventions are being tested in trial NCT01356771?
The interventions under investigation include: Surveys & Mailed Materials (OTHER).
Who is sponsoring clinical trial NCT01356771?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01356771 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.